Using electrical stimulation to treat bedwetting in children
Official title: Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Nocturnal Enuresis in Children
Run by Albany Medical College · NCT06135311 · Data updated 2026-11-12
This study is testing if a new electrical stimulation treatment can help children aged 5-17 who struggle with bedwetting after other methods haven't worked.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 17 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Albany Medical College Academic / other |
| Locations | 1 site (Albany, New York) |
| Status | Recruiting |
| Started | October 24, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT06135311 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 5-17 with nocturnal enuresis who have failed initial behavioral modification treatments.
✕Probably not a fit
Patients with daytime incontinence, those who have recently tried other treatments for bedwetting, or those with certain medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial involves children aged 5-17 who are experiencing primary nocturnal enuresis and have not responded to behavioral modifications. Participants will be randomized into two groups to receive transcutaneous electrical nerve stimulation (TENS) with different pulse widths: one group at 260 microseconds and the other at 50 microseconds. The TENS unit will be applied nightly for 30 minutes over a period of 30 days, with caregivers instructed on its use. The effectiveness of the treatment will be monitored through diaries documenting nighttime incontinence.
Why it matters
Potential benefit: If successful, this approach could provide an effective non-pharmacological treatment option for children suffering from bedwetting.
How similar studies have gone: While the use of TENS for nocturnal enuresis is a novel approach, similar neuromodulation techniques have shown promise in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Presenting with nocturnal enuresis (more than 1x a week) 2. Failed Behavioral modification treatment (limiting evening drinking, double voiding prior to bedtime, bowel habits, social anxiety factors) during the 30 day period prior to randomization 3. Ability to provide informed consent and assent and complete study requirements Exclusion Criteria: 1. Patients who have previously tried pharmacologic treatment for nocturnal enuresis, neuromodulation or other alternative therapy for urologic disorders within the past 30 days 2. Daytime incontinence symptoms 3. Known "high volume" voiders (determined from history) 4. Bedwetting episodes on the average of less than two times per week, 5. Medications predisposing to incontinence (eg, Lithium for bipolar disorder) 6. Other known voiding or neurologic disorders (eg, overactive bladder, myelomeningocele, interstitial cystitis, etc) 7. Secondary etiologies for nocturnal enuresis (eg, cystitis, obstructive sleep apnea, urinary fistulae, heart disease) 8. Any contraindications to usage of a TENS unit (pacemaker or other implantable device, lymphedema, pregnancy, malignancy, bleeding or clotting disorders, unhealthy tissue, seizure disorders, impaired cognition) 9. Any history of heart disease or complications
Where it's running
-
Albany Medical College
Albany, New York, United States Recruiting
Study contacts
- Principal investigator: Adam Howe, MD — Albany Medical College
- Study coordinator: Brenda Romeo, CCRC
- Email: romeob@amc.edu
- Phone: 518-262-3349
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single-Lumen Midline Catheter vs Ultrasound-Guided Peripheral IV by ED Nurses
This study tests whether a ultrasound-guided single-lumen midline catheter works better than an ultrasound-guided long peripheral IV for ED patients with difficult IV access, when inserted by bedside nurses.
-
Thoracentesis to remove lung fluid for adults hospitalized with worsening heart failure and pleural effusion
This study will test whether removing fluid around the lungs with thoracentesis plus usual heart-failure treatment helps reduce shortness of breath in adults hospitalized with acute decompensated heart failure and moderate-to-large pleural effusions.
-
Using patient-chosen visual art to improve hospital satisfaction during pregnancy admissions
This study tests if letting pregnant patients choose the artwork in their hospital room can make them feel happier and more satisfied during their stay.
-
Using vibrators to enhance sexual and pelvic floor function in women with urogynecological issues
This study is testing if using vibrators can help women with urogynecological issues improve their sexual and pelvic floor function.
-
Software fusion versus cognitive (visual) MRI-guided ultrasound biopsy for prostate cancer detection
This study will test whether MRI-targeted biopsy using software fusion or cognitive (visual) fusion finds more clinically significant prostate cancer in men with suspicious mp‑MRI lesions.
-
Using anti-inflammatory drugs to lower PSA levels in men
This study is testing if taking ibuprofen can lower PSA levels in men with high readings to help avoid unnecessary prostate biopsies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.